The US Drug Enforcement Administration (DEA) has just rescheduled Epidiolex—the recently-approved, cannabis-derived drug for rare forms of childhood epilepsy—from Schedule I to Schedule V. Schedule 1 drugs are not allowed to be prescribed by doctors due to their high potential for abuse, lack of medical use and limited safety data. Schedule V drugs are those considered to have medical use and carry a low potential for abuse, which means Epidiolex has crossed yet another regulatory hurdle to get to market. See More
Marinol Latest News
Get the latest updates on this drug from the GoodRx medical team
Doctors are increasingly faced with questions from patients about marijuana and its medical uses. A common question we hear is, “What’s the difference between the pill forms like Marinol (dronabinol) and medical marijuana?”
Let’s start with the fact that dronabinol (Marinol, Syndros), nabilone (Cesamet) and cannabidiol (Epidiolex) are medications approved by the FDA. Currently, there is no-FDA approved medical indication for prescribing marijuana. See More
Let’s start with the fact that Marinol is FDA approved for chemotherapy-induced nausea and vomiting, and anorexia from AIDS or cancer. Currently, there is no FDA approved medical indication for prescribing marijuana. So—why is one approved and not the other? Do they work? What are their differences?